NIH Testing Hyperimmune Intravenous Immunoglobulin Plus Remdesivir to Treat COVID-19
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir…